EUVIMEDEUVIMED entdecken
Crossref

Serum microRNAs for the assessment of symptomatically refractory gastroesophageal reflux disease despite acid suppression

Ryuto Yamada, Juntaro Matsuzaki, Takanori Kanai, Takahiro Ochiya, Tatsuhiro Masaoka

Esophagus · 2026-10 · 23 (4) · 1014-1022

DOI: 10.1007/s10388-026-01237-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Esophagus, online erschienen am 20.07.2026. Verfasst von Ryuto Yamada und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan. Hauptthemen laut MEDLINE: Gastroesophageal Reflux, MicroRNAs, Proton Pump Inhibitors. Die Arbeit nennt 26 Literaturangaben. Gefördert von: Japan Agency for Medical Research and Development, School of Medicine, Keio University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastroesophageal RefluxMicroRNAsProton Pump InhibitorsHumansFemaleMaleMiddle AgedBiomarkersAdultSurveys and QuestionnairesDepressionAnxietyAgedEsophagitis, Peptic

Stichwörter der Autor:innen

Gastroesophageal refluxProton pump inhibitorsSensitivitymicroRNAs

Substanzen

MicroRNAsProton Pump InhibitorsBiomarkers

Autor:innen und Institutionen

  • Division of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.
  • Division of Molecular and Cellular Medicine, National Cancer Center Research Institute, Tokyo, Japan.
  • Division of Interdisciplinary Genetics and Nanomedicine, Research Center for Drug Discovery, Keio University Faculty of Pharmacy, Tokyo, Japan.
  • Department of Molecular and Cellular Medicine, Institute of Medical Science, Tokyo Medical University, Tokyo, Japan.
  • Division of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan. tmasaoka@mbr.nifty.com.
  • Department of Gastroenterology and Hepatology, Kawasaki Municipal Hospital, 12-1, Shinkawa-dori, Kawasaki-ku, Kawasaki-city, Kanagawa, 210-0013, Japan. tmasaoka@mbr.nifty.com.

Förderung

  • Japan Agency for Medical Research and Development
  • School of Medicine, Keio University

Zitieren

APA

Yamada, R., Matsuzaki, J., Kanai, T., Ochiya, T., & Masaoka, T. (2026). Serum microRNAs for the assessment of symptomatically refractory gastroesophageal reflux disease despite acid suppression. Esophagus, 23(4), 1014-1022. https://doi.org/10.1007/s10388-026-01237-9

Vancouver

Yamada R, Matsuzaki J, Kanai T, Ochiya T, Masaoka T. Serum microRNAs for the assessment of symptomatically refractory gastroesophageal reflux disease despite acid suppression. Esophagus. 2026;23(4):1014-1022. doi:10.1007/s10388-026-01237-9

BibTeX
@article{Yamada2026,
  author = {Yamada, Ryuto and Matsuzaki, Juntaro and Kanai, Takanori and Ochiya, Takahiro and Masaoka, Tatsuhiro},
  title = {Serum microRNAs for the assessment of symptomatically refractory gastroesophageal reflux disease despite acid suppression},
  journal = {Esophagus},
  year = {2026},
  volume = {23},
  number = {4},
  pages = {1014--1022},
  doi = {10.1007/s10388-026-01237-9}
}
Kostenlos starten →